UNSPSC 51452702: Epsiprantel

This classification denotes an antihelminthic agent with the molecular formula C20H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0C1SPQ0FSR, chemically known as 2-(cyclohexylcarbonyl)-4-oxo-1,2,3,4,6,7,8,12b-octahydropyrazino(2,1-a)(2)benzazepine but generally known as epsiprantel, which bears US NIH Compound Identifier 72026. European Medicines Agency schedules Epsiprantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06590MIG.

UNSPSC 51452702 Epsiprantel, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The code nominally covers a single antihelmintic pharmaceutical ingredient, but the four recent opportunities solicited under this code procure naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer prescription program services. None of these solicitations request epsiprantel specifically. The activity reflects a mismatch between the code assignment and the actual goods and services being bought.

The issuing bodies span state health agencies, county health departments, city fire departments, and cooperative purchasing alliances. Seminole County, Florida posted an IFB on June 30, 2026 (response deadline July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county health building. The Texas Health and Human Services Commission issued a Request for Information on April 3, 2026 to explore vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The City of Tampa's Purchasing Department issued an IFB on March 25, 2026 (response deadline March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market opportunity exclusively for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration, issued an RFP posted January 20, 2026 (response deadline March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon through authorized wholesalers. The code shows recent activity across Florida, Texas, Florida, and Minnesota, but none of the solicitations reflect procurement of epsiprantel as a pharmaceutical active ingredient or finished dosage form.